Introducing Swiss Dream CBD, a truly innovative strain developed by the renowned Kannabia Seed Company.

Please note that under certain treatments, the plant may exhibit a slightly higher THC percentage, which Kannabia cannot be held responsible for.

Swiss Dream showcases an exceptional CBD/THC ratio of 26:1, accompanied by CBD levels reaching up to 7%.

It's the result of expertly reducing the THC content to nearly nonexistent, making it a clinical strain specifically tailored for patients seeking a THC-free experience.

Expect a lucid effect that induces a truly intoxicating sense of relaxation. One remarkable quality of Swiss Dream is its resilience to both environmental and internal stress conditions.

This makes it an ideal choice for first-time cultivators seeking therapeutic benefits. Despite its predominantly sativa morphology, it is easily manageable with controlled growth, particularly when cultivated indoors.

This branch-heavy producer showcases compact, bullet-shaped flowers with an olive green foliage. The floral spicy aroma beautifully contrasts with subtle hints of diesel and ginger.

Swiss Dream offers not only a relaxing effect and high productivity but also pest resistance, making it an al around desirable strain.

• Relaxing effect
• High productivity

Experience the unparalleled benefits of Swiss Dream CBD and unleash a world of relaxation without the psychoactive effects. 

Genetics: Swiss Dream CBD
Feminized Indica dominant hybrid
CBD: 7%
THC: 0,22%
Ratio: 26:1
Flowering cycle: 70-75 days
Harvest: October
Average height: 200 cm